Health Highlights, Nov. 1, 2021
FDA delays decision on Moderna vaccine for teens under 17: The company announced Sunday that the agency said it needs more time to examine data on a rare cardiac side effect seen in young males after Moderna’s second shot, with any approval likely pushed back to January 2022. Read moreContinue Reading